|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Amyloid Beta (1-40) ELISA Assay | Chagas (Trypanosoma cruzi) IgG ELISA Assay | Leishmania infantum IgG ELISA Assay | NSE ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27600 | 27713 | IB79809 | IB79808 | 420-85 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase sandwich ELISA for the determination of human Aß(1-40) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IgG class antibodies against Trypanosoma cruzi in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of antibodies against Leishmania infantum in human serum or plasma (citrate). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of NSE (Neuron-Specific Enolase) in human serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Metanephrine / Normetanephrine | Anti-Rituximab (Rituxan®) | Epstein-Barr Virus (EBNA-1) IgM | Epstein-Barr Virus (EBNA-1) IgG | Complement Factor P (Properdin) |
| Sample Type | Urine | Serum and plasma. | Serum, Blood Plasma | Serum, Blood Plasma | Human serum or EDTA plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.56 to 100.0 ng/mL | 7.81 to 500 pg/mL | Inquire | Inquire | 7.5 to 138.0 µg/L |
| Sensitivity | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 40 ng/mL | 0.69 U/mL | 0.62 U/mL | Inquire |
| Assay Time | 2 hours (incubation) | Overnight + 1 hr 30 mins (incubation) | 1 hr 45 mins (incubation) | 1 hr 45 mins (incubation) | 1 hrs 30 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |